We Message Board Posters Welcome You!
ABOUT CEL-SCI AND THEIR DRUG MULTIKINE
Lots of good details can be found on their website: Cel-Sci.com. But the best recap is their Corporate Presentation.
Probably the most accurate and concise articles written are:
- Setting The Record Straight on Cel-Sci
- On the Verge of Approval
- Learning From Bristol-Myers' Ipilimumab
Zacks provided a nice recap recently as well. Link here: ZACKS. They also provided an update after 3rd Quarter's 10Q was released. Link here: ZACKS 3Q
TRIAL SHOULD HAVE ENDED IN 2018, WHY THE 'DELAY"?
Delays are never good, right? Here is the thing... The trial ends when the 298th event (death) happens. But people aren't dying as fast as statistics would suggest for survival of Head and Neck cancer patients. Why? We believe its Multikine. During Geert's presentation at the HC Wainright sponsored conference on 9/10, he noted that the 298 event hasn't occurred.
On 3/29/19, the IDMC reviewed the UNBLINDED data for efficacy, safety and FUTILITY. Their recommendation: Continue the trail until the last event! Details Here
Need more proof and you're a Stats Junkie? Then head on over to the Google Sheets created by our "National Treasure" FOSCO and team from the iHub message boards. These sheets estimate that we are now past 10% of Standard Care.
STRAIGHT FROM THE CEO HIMSELF (BTW he has over 1M shares)
- On 6/18, this Conference video came out: Video
- On 5/16, a new interview came out: Video
- On 5/8, Geert issued a Press Release: Shareholder Letter
- Geert did an interview 5/2/19: ThinkEquity Interview
SHORTS ARE SPREADING RUMORS!
REVERSE SPLITS??? THAT'S RICH!
REVERSE SPLITS is the latest SHORT tactic! Yes, we have had 3 Reverse Splits. But that was then due to low share price. Did you know a Reverse Split REQUIRES Shareholder approval? Its true. This approval request is done via a Proxy. Here is the latest Proxy:
****DID YOU SEE ANY REQUEST FOR AN APPROVAL OF A REVERSE SPLIT!?***
Furthermore, why would we do a Reverse Split now that we are at $5.00? Are we at threat to be delisted? No! Here is why companies do Reverse Splits:
CASH CASH AND MORE CASH!
This is always an issue with Biotechs. Constant financing. Dilution. Wash, Rinse, Repeat.
The last 10Q as of 6/30/19 stated they have over $12M of cash. No offering until Spring 2020!
Visit Cash Page for current details
The Stock Price Will Never Amount To Anything! Really?
Really? We currently have a $295M (as of 7/2/19) Market Cap and a share price over $8.00. Do some due diligence. Upon a successful read out of the Phase III data, we are talking Billions and Billions! I wont give you share price expectations, but what I will give you is recent buyouts of other bios:
- Eli Lilly bought Loxo Oncology for about $8 billion. Just $8 billion.
- https://www.fool.com/investing/2018/07/05/3-best-biotech-acquisitions-of-2018-so-far.aspx
- https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_mergers_and_acquisitions
- Google the stock BPTH. Phase 2 Biotech. Take a look what happened there in just 1 day.
Do the math! We are at $295M with about 33M shares outstanding....How does one get to a $5B-$10B. Market Cap...? The multiples are insane, but its possible!
Shorts Will Lie, Lie and Lie
Bashers Bash. See why here: https://messageboardfools.com/bashers.htm
They will say anything to make your give up your shares. Stay long!